Risk factors
Jupiter Neurosciences (JUNS) risk factors
Item 1A of every Jupiter Neurosciences, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors99 risks19 new4 dropped27 reworded
Jupiter Neurosciences is facing severe going concern doubts, relying heavily on dilutive equity financing via a SEPA with Yorkville.
Filed Apr 01, 2026 - FY2024 10-K risk factors84 risks
Jupiter Neurosciences relies entirely on the success of its lead drug candidate JOTROL for rare and neurological diseases.
Filed Mar 28, 2025